ストックスクリーナーアプリを入手
1.34
4.96%
-0.07
アフターアワーズ：
1.37
0.03
+2.24%
Traws Pharma Inc (TRAW) 最新ニュース
Published on: 2026-01-11 07:18:09 - ulpravda.ru
Fed Meeting: Is Traws Pharma Inc. stock a buy before product launches2025 Market WrapUp & Weekly Market Pulse Updates - ulpravda.ru
How resilient is Traws Pharma Inc. stock in market downturnsTrade Exit Report & Short-Term Trading Alerts - ulpravda.ru
Why Traws Pharma Inc. stock remains on watchlists2025 Market Outlook & Consistent Profit Trade Alerts - ulpravda.ru
Is Traws Pharma Inc. stock cheap at current valuationMarket Activity Report & Community Trade Idea Sharing - ulpravda.ru
How Traws Pharma Inc. stock compares to industry benchmarksPortfolio Risk Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Comparing Miravant Medical Technologies (OTCMKTS:MRVT) and Traws Pharma (NASDAQ:TRAW) - Defense World
Traws Pharma Pushes Ahead on COVID and Flu Antivirals as Costs Fall and Pipeline Advances - MSN
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - Moscow-Pullman Daily News
Traws Pharma (NASDAQ:TRAW) Shares Down 3.5% – Time to Sell? - Defense World
How Traws Pharma Inc. stock compares to growth peersTechnical Resistance Breaks & Fast Growing Capital Gains - bollywoodhelpline.com
CLARKE TRAFFORD Insider Trades - Nasdaq
Why Traws Pharma Inc. (0T20) stock stays on top picksAnalyst Upgrades & Master Stock Selection - Bollywood Helpline
New COVID Pill Shows Promise Against Paxlovid in Early Head-to-Head Trial - MyChesCo
Life sciences leader behind a $900M pharma sale joins cancer firm - Stock Titan
Is Traws Pharma Inc a good long term investmentRetail Trading Trends & High Return Wealth Building - earlytimes.in
Momentum Shift: Will Traws Pharma Inc. (0T20) stock benefit from mergersMarket Sentiment Report & Real-Time Buy Zone Alerts - Улправда
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir - MSN
How Traws Pharma Inc. stock performs during Fed tightening cyclesJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - Улправда
How Traws Pharma Inc. stock reacts to global recession fears2025 Growth vs Value & AI Driven Stock Reports - Улправда
Why Traws Pharma Inc. (0T20) stock stays on buy lists2025 Biggest Moves & Consistent Profit Trading Strategies - DonanımHaber
Aug Momentum: How Traws Pharma Inc. stock reacts to global recession fearsWeekly Investment Recap & Free Technical Confirmation Trade Alerts - Улправда
Will Traws Pharma Inc. (0T20) stock profit from fiscal stimulusJuly 2025 Highlights & Real-Time Volume Surge Alerts - Улправда
Traws Pharma's Oral COVID Drug Shows Comparable Results To Paxlovid - Benzinga
Traws Pharma, Inc. Announces Positive Interim Data for Ratutrelvir in COVID-19 Study - TradingView — Track All Markets
Traws Pharma Reports Promising Interim Data for Ratutrelvir, Showing Favorable Profile Compared to PAXLOVID™ in COVID-19 Treatment - Quiver Quantitative
Traws Pharma (NASDAQ: TRAW) highlights positive Phase 2 COVID data results - Stock Titan
Traws Pharma Reports Positive Interim Clinical Data - One News Page
Ratutrelvir shows promising interim results in COVID-19 trial - Investing.com
Traws Pharma (TRAW) reports director RSU and stock option awards - Stock Titan
[Form 4] Traws Pharma, Inc. Insider Trading Activity - Stock Titan
Traws Pharma, Inc. (TRAW) director awarded RSUs and stock options in 2025 grant - Stock Titan
Traws Pharma (TRAW) director reports equity awards details in Form 4 filing - Stock Titan
Traws Pharma (NASDAQ: TRAW) CEO reports new RSU and stock option awards - Stock Titan
Traws Pharma (TRAW) CSO receives new RSUs and stock options grant - Stock Titan
Traws Pharma (NASDAQ: TRAW) discloses CMO equity grants of stock and options - Stock Titan
Traws Pharma (TRAW) insider granted RSUs and options on 12/12/2025 as equity awards - Stock Titan
Traws Pharma (Nasdaq: TRAW) approves stock option and RSU grants for top executives - Stock Titan
Traws Pharma Earnings Notes - Trefis
Published on: 2025-12-12 06:22:07 - moha.gov.vn
Traws Pharma (TRAW) – Analysts’ Recent Ratings Changes - Defense World
Traws Pharma (NASDAQ:TRAW) Upgraded at Zacks Research - Defense World
0T20 Forecast — Price Target — Prediction for 2026 - TradingView
Traws Pharma (NASDAQ:TRAW) Cut to “Sell” at Wall Street Zen - Defense World
HC Wainwright Estimates Traws Pharma Q4 Earnings - Defense World
Can Traws Pharma Inc. (0T20) stock sustain institutional flowsTrade Risk Assessment & Consistent Growth Equity Picks - Newser
What earnings margins imply for Traws Pharma Inc. (0T20) stock2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
HC Wainwright Begins Coverage on Traws Pharma (NASDAQ:TRAW) - Defense World
Is Traws Pharma Inc. stock trading near support levelsTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
How Traws Pharma Inc. (0T20) stock behaves under inflation pressureJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock benefit from sector leadership2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Why ETFs are accumulating Traws Pharma Inc. (0T20) stockQuarterly Earnings Report & Entry and Exit Point Strategies - Newser
Is Traws Pharma Inc. (0T20) stock positioned for secular growthWeekly Loss Report & Weekly High Return Stock Forecasts - Newser
Is Traws Pharma Inc. (0T20) stock prepared for digital transition2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
0.90%
大文字化:
|
ボリューム (24 時間):